Sign Up to like & get
recommendations!
1
Published in 2022 at "Biotechnology Journal"
DOI: 10.1002/biot.202100266
Abstract: The production of biopharmaceuticals in engineered plant‐based systems is a promising technology that has proven its suitability for the production of various recombinant glyco–proteins that are currently undergoing clinical trials. However, compared to mammalian cell…
read more here.
Keywords:
broadly neutralizing;
human broadly;
neutralizing anti;
anti hiv ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2021 at "Drugs"
DOI: 10.1007/s40265-021-01621-y
Abstract: Fabry disease (FD) is a rare X-linked lysosomal storage disorder caused by mutations in the α-galactosidase A (AGAL/GLA) gene. The lysosomal accumulation of the substrates globotriaosylceramide (Gb3) and globotriaosylsphingosine (lyso-Gb3) results in progressive renal failure,…
read more here.
Keywords:
enzyme replacement;
fabry disease;
disease;
neutralizing anti ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2019 at "Scientific Reports"
DOI: 10.1038/s41598-019-48592-5
Abstract: The main targets for neutralizing anti-hepatitis C virus (HCV) antibodies (HCV-nAbs) are the E1 and E2 envelope glycoproteins. We have studied the characteristics of HCV-nAbs through a retrospective study involving 29 HIV/HCV-coinfected patients who achieved…
read more here.
Keywords:
hcv antibodies;
hcv;
hiv hcv;
neutralizing anti ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Haemophilia"
DOI: 10.1111/hae.14711
Abstract: Autoimmune factor X (FX or F10) deficiency (AiF10D) is an extremely rare acquired haemorrhagic disorder characterized by a severe reduction in FX activity due to autoantibodies against FX.
read more here.
Keywords:
non neutralizing;
anti factor;
identification non;
neutralizing anti ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2021.780191
Abstract: Langerhans cell histiocytosis (LCH) is an inflammatory myeloid neoplasm characterised by the accumulation into granulomas of apoptosis-resistant pathological dendritic cells (LCH-DCs). LCH outcome ranges from self-resolving to fatal. Having previously shown that, (i) monocyte-derived DCs…
read more here.
Keywords:
lch patients;
dcs lch;
neutralizing anti;
expression ... See more keywords